Rigel Pharmaceuticals Stock Technical Analysis
| RIGL Stock | USD 18.98 0.07 0.37% |
As of the 27th of March, Rigel Pharmaceuticals holds the Semi Deviation of 3.62, risk adjusted performance of 0.057, and Coefficient Of Variation of 1726.5. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rigel Pharmaceuticals, as well as the relationship between them. Please check Rigel Pharmaceuticals downside deviation, jensen alpha, as well as the relationship between the Jensen Alpha and downside variance to decide if Rigel Pharmaceuticals is priced some-what accurately, providing market reflects its current price of 18.98 per share. Given that Rigel Pharmaceuticals has jensen alpha of 0.2483, we recommend you to check out Rigel Pharmaceuticals's recent market performance to make sure the company can sustain itself at a future point.
Rigel Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Rigel, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to RigelRigel |
Rigel Pharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 31.33 | Buy | 6 | Odds |
Most Rigel analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Rigel stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Rigel Pharmaceuticals, talking to its executives and customers, or listening to Rigel conference calls.
Rigel Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Rigel Pharmaceuticals Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Rigel Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Rigel Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Rigel Pharmaceuticals. You can use it to identify possible trend reversals for Rigel Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Rigel Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Rigel Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Rigel Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.05 , which means Rigel Pharmaceuticals will continue generating value for investors. It has 122 observation points and a regression sum of squares at 98.18, which is the sum of squared deviations for the predicted Rigel Pharmaceuticals price change compared to its average price change.About Rigel Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Rigel Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Rigel Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Rigel Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Rigel Pharmaceuticals. By analyzing Rigel Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Rigel Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Rigel Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2024 | 2025 (projected) | Graham Number | 2.35 | 2.24 | Receivables Turnover | 4.31 | 4.09 |
Rigel Pharmaceuticals March 27, 2025 Technical Indicators
Most technical analysis of Rigel help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Rigel from various momentum indicators to cycle indicators. When you analyze Rigel charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.057 | |||
| Market Risk Adjusted Performance | 0.1279 | |||
| Mean Deviation | 3.17 | |||
| Semi Deviation | 3.62 | |||
| Downside Deviation | 3.95 | |||
| Coefficient Of Variation | 1726.5 | |||
| Standard Deviation | 4.37 | |||
| Variance | 19.11 | |||
| Information Ratio | 0.0562 | |||
| Jensen Alpha | 0.2483 | |||
| Total Risk Alpha | 0.2559 | |||
| Sortino Ratio | 0.0623 | |||
| Treynor Ratio | 0.1179 | |||
| Maximum Drawdown | 26.07 | |||
| Value At Risk | (4.92) | |||
| Potential Upside | 7.91 | |||
| Downside Variance | 15.57 | |||
| Semi Variance | 13.09 | |||
| Expected Short fall | (3.52) | |||
| Skewness | 0.6972 | |||
| Kurtosis | 1.89 |
Rigel Pharmaceuticals March 27, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Rigel stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 8,262 | ||
| Daily Balance Of Power | 0.10 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 19.22 | ||
| Day Typical Price | 19.14 | ||
| Price Action Indicator | (0.21) |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rigel Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Rigel Stock please use our How to buy in Rigel Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rigel Pharmaceuticals. If investors know Rigel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rigel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 17.867 | Earnings Share 0.99 | Revenue Per Share | Quarterly Revenue Growth 0.609 | Return On Assets |
The market value of Rigel Pharmaceuticals is measured differently than its book value, which is the value of Rigel that is recorded on the company's balance sheet. Investors also form their own opinion of Rigel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rigel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rigel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rigel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rigel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rigel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rigel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.